{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 7,
        "Importance": 9,
        "Impact": 8,
        "Duration": 6,
        "Virality": 7,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 5,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Commented on: \"AbbVie: Attractive Valuation, Growth Prospects & Yield\"",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 5,
            "Impact": 4,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 6,
            "Specificity": 6,
            "Sector_Spread": 3,
            "Tech_Mentions": 2
        },
        {
            "News_content": "@ibbyhabib I understand that.. My point is how much money can be made off a $21B purchase??",
            "Correlation": 6,
            "Sentiment": 4,
            "Importance": 4,
            "Impact": 3,
            "Duration": 3,
            "Virality": 5,
            "Source_Score": 5,
            "Specificity": 5,
            "Sector_Spread": 2,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$ABBV ripping higher #stocks #stockaction es_F #nyse #trading #money",
            "Correlation": 8,
            "Sentiment": 8,
            "Importance": 6,
            "Impact": 7,
            "Duration": 4,
            "Virality": 6,
            "Source_Score": 5,
            "Specificity": 7,
            "Sector_Spread": 4,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Fascinating twitterpalooza over the $ABBV acquisition of $PCYC following corporate CCs;",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 7,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "@bradloncar @ymscapital wow didn't see that coming. Not how I would spend $21B but hey not my money",
            "Correlation": 7,
            "Sentiment": 5,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 6,
            "Source_Score": 5,
            "Specificity": 7,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @Loftus: AbbVie to buy Pharmacyclics in $21 billion deal via @WSJ @jonathanrockoff",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 8,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "#AbbVie : La valeur du jour Ã  Wall Street - ABBVIE s'offre Pharmacyclics pour...",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 6,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "@franklin19788 Your tweet has been featured on Market Parse, for iPhone.",
            "Correlation": 3,
            "Sentiment": 5,
            "Importance": 3,
            "Impact": 2,
            "Duration": 2,
            "Virality": 4,
            "Source_Score": 4,
            "Specificity": 3,
            "Sector_Spread": 1,
            "Tech_Mentions": 1
        },
        {
            "News_content": ".@matthewherper @MaverickNY As @lomu_j mentioned,one has to wonder if $ABBV is less confident about ABT-199 after seeing 17p del data?",
            "Correlation": 7,
            "Sentiment": 5,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 5,
            "Source_Score": 6,
            "Specificity": 7,
            "Sector_Spread": 4,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Analysts Mixed On Premium For Pharmacyclics:",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 5,
            "Source_Score": 6,
            "Specificity": 7,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$ABBV $PCYC",
            "Correlation": 6,
            "Sentiment": 5,
            "Importance": 5,
            "Impact": 4,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 4,
            "Specificity": 5,
            "Sector_Spread": 3,
            "Tech_Mentions": 1
        },
        {
            "News_content": "AbbVie Buys Pharmacyclics: The Story Is Likely Far From Over",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 7,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Wow! AbbVie to Acquire Pharmacyclics for $21 Billion",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 8,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 6,
            "Tech_Mentions": 2
        },
        {
            "News_content": "@Street_Insider: AbbVie to Acquire Pharmacyclics for $21 Billion (no $JNJ)",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 7,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$ABBV to buy $PCYC for $261.25/share: 58% cash and 42% stock",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 7,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        },
        {
            "News_content": "$ABBV $JNJ News: \"AbbVie to acquire Pharmacyclics for $21B\"",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 6,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$ABBV",
            "Correlation": 5,
            "Sentiment": 4,
            "Importance": 3,
            "Impact": 3,
            "Duration": 2,
            "Virality": 3,
            "Source_Score": 3,
            "Specificity": 4,
            "Sector_Spread": 2,
            "Tech_Mentions": 1
        },
        {
            "News_content": "@BioRunner59 @CashRocket Has to be a result of the $ABBV / $PCYC deal.",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 5,
            "Source_Score": 5,
            "Specificity": 7,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        }
    ]
}